Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Previewing Retail Sector Earnings as Inflation Climbs
04:33pm, Friday, 13'th May 2022
With respect to the Retail sector's 2022 Q1 earnings season scorecard, we now have results from 21 of the 34 retailers in the S&P 500 index. Here's how the companies are performing so far and what to
Six Dividend-Paying Stocks With Low Payout Ratios to Buy
07:30am, Thursday, 12'th May 2022
These six dividend-paying stocks have low P/E multiples, good dividend yields, and low payout ratios, leaving room for share buybacks. The post Six Dividend-Paying Stocks With Low Payout Ratios to Buy
Here's Why You Should Hold on to CVS Health (CVS) For Now
12:03pm, Wednesday, 11'th May 2022
Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.
Baby formula shortage forces CVS Health to limit purchases
08:07am, Tuesday, 10'th May 2022
Pharmacy chain CVS Health Corp said on Tuesday it has limited in-store and online purchases of baby formula products to three per order, citing a supply shortfall and surging consumer demand.
Walgreens, CVS, Walmart begin $878 million opioid trial in Ohio
06:08am, Tuesday, 10'th May 2022
CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc on Tuesday begin a first-of-its-kind trial to determine what the pharmacy chains owe for their role in the opioid epidemic in two Ohio cou
CVS Health: Share Repurchases, Deleveraged Balance Sheet, And A Dividend Catalyst
05:42pm, Monday, 09'th May 2022
CVS reassures its investors by aggressively purchasing their own shares, deleveraging their balance sheet, and maintaining a growing dividend. The company unlocks new opportunities with their diversif
5 Health Care Stocks For Your May 2022 Watchlist
03:30pm, Thursday, 05'th May 2022
Should investors' be looking at these health care stocks this earnings season?
6 Undervalued Consumer Brand Stocks Worth Buying Now Before a Recession Hits
07:58pm, Wednesday, 04'th May 2022
6 undervalued consumer brand stocks worth buying now. The six undervalued stocks have strong consumer brands that will carry them through the end of a recession as they keep paying dividends.
CVS Health CEO Karen Lynch says company has strong revenue growth in Q1
04:34pm, Wednesday, 04'th May 2022
Karen Lynch, CVS Health CEO and president, joins 'Closing Bell' to discuss its first quarter earnings report, how Covid-19 will impact its business going forward, and more.
Why CVS Health Shares Are Rising
03:17pm, Wednesday, 04'th May 2022
CVS Health Corp (NYSE: CVS) shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guida
CVS Health (CVS) Q1 Earnings Top Estimates, '22 EPS View Up
12:47pm, Wednesday, 04'th May 2022
CVS Health (CVS) reports better-than-expected results for Q1, with robust segmental performance driving the top line.
CVS Health Corporation (CVS) CEO Karen Lynch on Q1 2022 Results - Earnings Call Transcript
12:23pm, Wednesday, 04'th May 2022
CVS Health Corporation (NYSE:CVS ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Tom Cowhey - Senior Vice President, Capital Markets Karen Lynch - President and Chief Ex
CVS Leans on Tech, Robotics to Drive Post-COVID Efficiencies as Store Count Declines
11:26am, Wednesday, 04'th May 2022
With its lucrative COVID vaccine and testing franchise on the decline, the nation's largest pharmacy retailer said Wednesday (May 4) that it was looking for ways to deploy new tech to help streamline
CVS boosts outlook as prescription demand outweighs COVID vaccine dip
11:20am, Wednesday, 04'th May 2022
CVS Health boosted its annual forecast after processing more prescriptions and adding hundreds of thousands of customers to its health insurance business in the first quarter.
CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates
09:02am, Wednesday, 04'th May 2022
CVS Health (CVS) delivered earnings and revenue surprises of 3.74% and 1.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
